Trials / Conditions / GATA2
GATA2
4 registered clinical trials studyying GATA2 — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Allogeneic Hematopoietic Stem Cell Transplantation With Briquilimab-Based Conditioning in Participants With GA NCT05907746 | National Cancer Institute (NCI) | Phase 2 |
| Recruiting | Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations NCT01861106 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Pilot and Feasibility Study of Reduced-Intensity Hematopoietic Stem Cell Transplant for MonoMAC NCT00923364 | National Cancer Institute (NCI) | Phase 2 |
| Recruiting | Genetic Analysis of Immune Disorders NCT00001467 | National Institute of Allergy and Infectious Diseases (NIAID) | — |